162 FERTILITY OF BEEF RECIPIENTS FOLLOWING A FIXED-TIME EMBRYO TRANSFER PROTOCOL WHICH INCLUDED FOLLICLE STIMULATING HORMONE DILUTED IN HYALURONAN

2013 ◽  
Vol 25 (1) ◽  
pp. 229
Author(s):  
J. W. Thorne ◽  
C. R. Looney ◽  
J. F. Hasler ◽  
D. K. Hockley ◽  
D. W. Forrest

This study was performed to test the viability of administering Folltropin-V® (FSH, Bioniche Animal Health) diluted in hyaluronan (MAP-5 50 mg, sodium hyaluronate, Bioniche Animal Health) to beef cows enrolled in a recipient synchronization protocol to evaluate its effect on recipient fertility. All recipients were administered an estradiol 17β (2.5 mg, IM) and progesterone (50 mg, IM) combination injection on Day 0, a CIDR® (progesterone 1.34 g, Pfizer Animal Health, Groton, CT, USA) was inserted for 7 days. Lutalyse® (dinoprost tromethamine, Pfizer Animal Health, 25 mg, IM) was administered at the time of CIDR removal on Day 7, and estradiol 17β (1 mg, IM) was administered on Day 8. On Day 16, the presence of at least one corpus luteum, detected via ultrasound, resulted in the recipient receiving an embryo (both fresh and frozen–thawed embryos were used). Embryos were not transferred into cows that did not show ultrasonic evidence of a CL. Dependent variables for which data were collected included circulating progesterone levels at the time of transfer and CL diameter, area, and circumference; measured in millimeters. The total study (n = 274) consisted of both wet (n = 85) and dry (n = 189) cows and included both Bos indicus (Brahman-influenced) crossbred (n = 93) and Bos taurus (Angus-based) cows (n = 181). The experiment consisted of cows being placed in either the treated or control groups, with treated cows receiving a single 40 mg (1 mL) IM injection of Folltropin-V in hyaluronan on Day 5 and control cows receiving no additional injections. Results are shown in Table 1. Transfer rate, conception rate, and pregnancy rate were tested for significance with chi-square analysis and remaining statistics were analyzed with a t-test: two-sample assuming equal variances. There were no significant differences found between the treated and control groups for transfer rate, conception rate, or pregnancy rate. Corpus luteum diameter was shown to be larger in control cows (P < 0.05); however, CL area and circumference did not differ significantly. Folltropin-V given with hyaluronan at a 40-mg dose on Day 5 did not improve fertility, induce a larger CL, or increase circulating progesterone levels in synchronized beef recipients as hypothesized. Further work is needed with Folltropin-V in hyaluronan to determine if an alternative dose or timing of administration would be more appropriate for improving fertility in recipients. Table 1.Fertility data in beef recipients following synchronization for fixed-time embryo transfer with a protocol that included (Treated) or did not include (Control) FSH in hyaluronan

2009 ◽  
Vol 21 (1) ◽  
pp. 246 ◽  
Author(s):  
R. G. Steel ◽  
J. F. Hasler

Traditionally, successful superstimulation of cattle depended on initiating injections of gonadotrophin at mid-cycle, approximately at second follicular wave emergence. This approach limited the convenience of scheduling donors for superstimulation. With the use of intravaginal progesterone-releasing devices and estradiol 17β, superstimulation can be initiated successfully at any time of the estrous cycle. However, because estradiol cannot be legally injected into cattle in an increasing number of countries, the efficacy of GnRH as an estradiol substitute was investigated. A retrospective analysis was performed on data collected in a commercial bovine embryo transfer program over a period of several years. All donors were lactating dairy cows at least two years of age; approximately 75% were comprised of Holstein and the remainder of Jersey, Guernsey, or Brown Swiss breeds. The three treatments employed were (1) Controls injected twice daily for 4 days with a total of 240 to 400 mg of porcine FSH (Folltropin-V, Bioniche Animal Health, Inc.) in decreasing doses starting between day 7 and day 14 of diestrus, with PG (Lutalyse, Pfizer Animal Health) given at the time of FSH injections no. 5 (35 mg) and 6 (25 mg); (2) Estradiol females received a CIDR (Pfizer Animal Health), 5.0 mg estradiol 17β and 100 mg progesterone in oil on random days of the estrous cycle; FSH was initiated 4 days later as described for controls with CIDR removal at the time of FSH injection no. 6; (3) GnRH females received a CIDR on random days of the estrous cycle and 100 μg GnRH on day 1.5 following CIDR insertion; FSH was initiated 60 h after GnRH injection as described for controls with CIDR removal at the time of FSH injection no. 6. All donors were inseminated with one straw of frozen semen 12 and 24 h after the onset of estrus. Embryos were nonsurgically recovered 7 to 8 days after onset of estrus. Only embryos of grades 1 to 3 (IETS classification) were included in the data. Data were analyzed by ANOVA and Tukey’s hsd test was used to distinguish significance among means as shown in Table 1. Estradiol females produced approximately 2 more ova/embryos per procedure than Control and GnRH groups and an average of 0.8 more embryos per female than did the Control group, but there was no difference compared to the GnRH group. Similar to what has been shown in other commercial embryo transfer data sets, nearly 25% of the donors in each group failed to produce at least one good embryo. Clearly, all three treatments resulted in efficacious superstimulation. In light of the legality issues surrounding the use of estradiol, this study shows that GnRH can be used quite successfully to superstimulate dairy cattle at random times of the estrous cycle. Table 1.Average numbers of ova and embryos recovered from dairy cows superstimulated with three different protocols We thank G.E. Seidel, Jr. and S.C. Purcell for assistance with statistical analysis.


2013 ◽  
Vol 25 (1) ◽  
pp. 156
Author(s):  
D. Romero ◽  
G. Romero ◽  
G. Veneranda ◽  
L. Filippi ◽  
D. Racca ◽  
...  

An experiment was designed to compare pregnancy rates in lactating dairy cows synchronized with a 7-day CIDR-Synch or a 5-day CIDR-Synch program and to determine if the addition of a second prostaglandin F2α (PGF) injection to the 7-day CIDR-Synch program would improve pregnancy rates following fixed-time AI (FTAI). The experiments were performed on 2 dairy farms in Argentina, with year-round calving and a mixed feeding system (35% grazing plus 65% corn silage and grain). Cows (n = 621) were 39.3 ± 6.5 days in milk (DIM, mean ± SD) when they were enrolled in the program, had 2.4 ± 1.5 lactations and a body condition score (BCS) of 3.1 ± 0.2 (range: 2.7 to 4.0). All cows received a pre-synchronization treatment with 2 doses of prostaglandin (PGF, 25 mg of dinoprost, Lutalyse, Pfizer Animal Health, Argentina) 14 days apart, and 11 days after the second PGF (Day 0) received 10 µg of Buserelin (GnRH, Receptal, MSD-Intervet, Argentina) and a CIDR device (1.9 g of progesterone, Pfizer Animal Health). Cows were randomly allocated to 1 of 3 groups. The CIDR devices were removed and PGF was administered to cows in Groups 1 and 2 on Day 7. A second GnRH was given 56 h later and cows experienced FTAI 16 h after gonadotropin-releasing hormone (GnRH) injection (i.e. 72 h after CIDR removal). Cows in Group 2 also received a second PGF injection on the afternoon of Day 7. Cows in Group 3 had the CIDR removed and received 2 PGF injections 12 h apart on Day 5. A second dose of GnRH was given and FTAI was performed at the same time, on Day 8 (i.e. 72 h after CIDR removal). All cows were examined by ultrasonography (Aloka 500V, Aloka, Tokyo, Japan) on the day of the first PGF injection and at CIDR removal to determine the presence and number of corpora lutea (CL), and 30 days after FTAI to determine pregnancy status. Data were analyzed by logistic regression to determine the effects of treatment, parity, days postpartum, milk production, BCS, presence of a CL at enrollment, and number of CL at the time of CIDR removal on pregnancy rates. Overall pregnancy rates did not differ among groups: 32.9% (68/207), 38.2% (78/204), and 38.3% (80/209) for Groups 1, 2, and 3, respectively (P = 0.2). Although the number of CL present at CIDR removal did not significantly affect pregnancy rates (P = 0.4), pregnancy rates in cows with 1 CL in Groups 1 and 2 tended to differ [29.0% (11/38) v. 48.9% (21/43); P < 0.07], but neither differed from that in Group 3 [37.2% (16/43)]. No differences were detected among groups in cows without a CL at CIDR removal [overall pregnancy rate: 29.4% (5/17)] and those with ≥2 CL [overall pregnancy rate: 36.1% (173/479)]. Among the other variables evaluated, first-parity cows had 1.96 (1.38–2.78) times more chance of getting pregnant than second-or-more-parity cows (P = 0.002) and cows with BCS >3 had 1.63 (1.16–2.28) times more chance of getting pregnant than those with BCS <3 (P = 0.003). Finally, herd, days postpartum, milk production, and presence of a CL at enrollment did not significantly affect pregnancy rates. We concluded that the 3 treatments resulted in similar pregnancy rates for lactating dairy cows and that the benefit of adding a second PGF injection to the 7-day protocol was only marginal in cows with 1 CL at CIDR removal.


2020 ◽  
Vol 17 (2) ◽  
Author(s):  
Alfonso Pérez-Mora ◽  
José Candelario Segura-Correa ◽  
Jorge Alonso Peralta-Torres

2016 ◽  
Vol 28 (2) ◽  
pp. 184
Author(s):  
M. Pelizzari ◽  
A. Tribulo ◽  
J. Garzon ◽  
B. Bernal ◽  
R. Tribulo ◽  
...  

A retrospective analysis of factors that affect pregnancy rates from 4214 fresh in vitro-produced (IVP) embryos that were transferred at a fixed-time (FTET) in 20 different farms. Recipients were all cycling cows or heifers that were synchronized with 1 of 3 treatments: 1) treatments with progesterone (P4) devices and 2 mg of oestradiol benzoate (EB) on Day 0 (day of insertion) and 24 h after device removal (Day 8); 2) treatments with P4 devices and EB on Day 0, but with 0.5 mg of oestradiol cypionate (ECP) at device removal (Day 8); or 3) treatments with P4 devices and GnRH on Day 0 and a second GnRH 60 h after device removal (Day 5). Cows in all treatment groups also received 500 µg of cloprostenol (prostaglandin F2α) at the time of P4 device removal and 400 IU of eCG either at device removal or 3 days before device removal. All embryos were transferred 7 or 8 days after the expected time of oestrus (24 h after EB, 48 h after ECP or at the time of the second GNRH for each synchronization treatment, respectively). On the day of embryo transfer, recipients were examined by ultrasonography and those with corpus luteum >14 mm in diameter received a fresh, IVP embryo in the uterine horn ipsilateral to the corpus luteum. Pregnancy rates were determined by ultrasonography 35 days after FTET. Data were analysed by logistic regression. Independent variables were classified into the following three categories. 1) Factors related to the recipient and the environment; there were no significant differences in pregnancy rates for corpus luteum diameter (≥14 and <16 mm, ≥16 and <18 mm, or ≥18 mm; P = 0.46), number of corpus luteum (1 or ≥2; P = 0.26), and category of recipient (cow or heifer; P = 0.21). However, there were significant effects of farm (P = 0.01) and body condition score (BCS; P = 0.01). Cows with BCS ≥4.5 (1 to 5 scale) resulted in lower pregnancy rates (4/20, 20.0%) than those with BCS 2 (74/225, 32.9%), 2.5 (502/1434, 35.0%), 3 (570/1467, 38.9%), 3.5 (193/532, 36.3%), and 4 (44/118, 37.3%). 2) Factors related to the synchronization treatment; there were no significant differences between recipients receiving eCG at device removal (84/209, 40.2%) or 3 days before device removal (874/2291, 38.1%; P = 0.35). However, recipients synchronized with P4 devices and ECP had higher (P = 0.01) pregnancy rates (232/483, 48.0%) than those treated with EB (679/1888, 36.0%) or gonadotropin-releasing hormone (47/129, 36.4%). 3) Factors related to the embryo transfer technique; day of the recipient’s oestrous cycle (P = 0.36), stage of embryo transferred (IETS stages 6 or 7; P = 0.62), and operator (P = 0.57) did not affect pregnancy rates. However transfers made in the anterior third of the uterine horn resulted in higher (649/1545, 42.0%) pregnancy rates than those in the mid-third (845/2511, 33.6%) or in the distal third (6/35, 17.1%; P = 0.01). It was concluded that factors related to the recipient and the environment (farm and BCS), the synchronization treatment (ECP), and the embryo transfer technique (site of deposition) affect pregnancy rates in recipients of embryos produced in vitro and transferred at a fixed time.


2014 ◽  
Vol 26 (1) ◽  
pp. 119
Author(s):  
J. B. S. Borges ◽  
D. X. Thedy

Successful establishment of pregnancy in the cow depends on early rise of progesterone (P4) to improve embryo development. The present study was carried out to determine the corpus luteum (CL) function and pregnancy rate following the administration of 1.500 IU of hCG in suckled beef cows on Day 4 after fixed-time AI (FTAI). Crossbred Angus cows (n = 429), 40 to 70 days postpartum, were synchronized using 2 mg of oestradiol benzoate (EB) i.m. and an intravaginal progesterone-releasing device containing 1 g of P4 for 7 days. At device removal, prostaglandin F2a (150 mg of D-cloprostenol) was injected i.m.; 24 h later, 1 mg of EB was given and the FTAI were done 30 to 36 h after EB using semen of just 1 bull. Cows were assigned alternatively to receive 1.500 IU of hCG i.m. (n = 200) or 1 mL of saline i.m. (n = 229) on Day 4 after FTAI. Ovaries were examined by transrectal ultrasonography (n = 71) on Days 4 and 7 to detect the presence and to measure the area of CL. Blood samples were collected on Days 4, 7, 10, 14, and 30 post-oestrus to determine P4 concentration by RIA. Pregnancy diagnoses were done 30 days after FTAI. The effects of treatments on CL area and serum P4 levels were analysed by ANOVA (Proc GLM, SAS Institute Inc., Cary, NC, USA) and pregnancy rates compared by chi-square (Proc CATMOT, SAS). The induction of accessory CL determined on Day 7 was 44% in cows treated with hCG and not observed in the control group. The area of the CL on Day 7 was significantly higher (P < 0.01; 3.37 ± 2.56 v. 2.56 ± 0.22 cm2) in the hCG group. Despite the increase in CL size, the mean levels of P4 on Days 4, 7, 10, 14, and 30 post-AI indicated no difference (P > 0.05) in CL function between control and hCG-treated cows. On Day 30, pregnancy rates were not different (P = 0.08), at 46.7 and 55% for control and hCG-treated cows, respectively. In conclusion, administration of 1.500 IU of hCG on Day 4 post-FTAI did not improve pregnancy rate in suckled beef cows.


2012 ◽  
Vol 24 (1) ◽  
pp. 167
Author(s):  
A. Shirasawa ◽  
Y. Nakamura ◽  
A. Ideta ◽  
Y. Oono ◽  
M. Urakawa ◽  
...  

Recipient animals for bovine embryo transfer (ET) are routinely selected according to the morphology of the corpus luteum (CL) estimated by rectal palpation. However, rectal palpation is not a precise method of diagnosing the functional status of a CL. Ovarian ultrasonography (US) may be used to improve such diagnoses. The aim of this study was to evaluate the relationship between ultrasonographic images of CL and pregnancy rates after ET in Holstein heifers to determine whether US can be used to select recipients for ET. Recipient heifers (n = 285) were selected by detection of natural oestrus or following oestrus synchronization using a progesterone-releasing intravaginal device (PRID; ASKA Pharmaceutical, Tokyo, Japan). Transrectal US was performed immediately before ET, on Days 6 to 8 of the oestrous cycle (oestrus = Day 0), using a B-mode scanner (HS1500V; Honda Electronics Co. LTD, Aichi, Japan) equipped with a 7.5-MHz linear-array transducer designed for intrarectal placement. A cross-sectional image of the maximal area of the CL and luteal cavity was obtained. The areas of the CL and luteal cavity were each calculated using the formula for the area of an ellipse (height/2 × width/2 × π). (1) Ultrasonic morphology of CL was classified into 3 types: without cavity (n = 128), with cavity (n = 145) and with blood clot (n = 12). (2) The luteal cavity was categorized into 3 groups: small (<100 mm2, n = 93), medium (100 ≤ x < 200 mm2, n = 32) and large (≥200 mm2, n = 20). (3) Luteinized tissue area (total area of CL minus the area of the luteal cavity) was categorized into 3 groups: small (<250 mm2, n = 61), medium (250 ≤ x < 350 mm2, n = 128) and large (≥350 mm2, n = 84). In vivo–produced embryos were transferred nonsurgically into the uterine horn ipsilateral to the CL. Pregnancy was determined by transrectal US on Days 30 to 40 of gestation. The pregnancy rates of each experimental group were analysed by logistic regression. In this study, the pregnancy rate did not differ significantly in each experimental group: (1) without cavity: 77.3% (99/128), with cavity: 75.2% (109/145) and blood clot: 75.0% (9/12); (2) small cavity: 73.1% (68/93), medium: 75.0% (24/32) and large: 85.0% (17/20). The mean area of the cavity was 100.8 ± 110.3 mm2 (mean ± standard deviation) and recipients with 0 to 539.7 mm2 sized cavities had successful pregnancies (observational range was 0 to 539.7 mm2). (3) The pregnancy rates of recipients that had small, medium and large luteinized tissue were 77.0% (47/61), 75.0% (96/128) and 77.4% (65/84), respectively. The mean area of luteinized tissue was 318.9 ± 90.3 mm2 and 155.0 to 620.0 mm2 sized luteinized tissue had pregnancy success (observational range was 132.8 to 620.0 mm2). In conclusion, the results from this study indicate that the presence of a luteal cavity or blood clot has no detrimental effect on pregnancy success after ET in Holstein heifers. Furthermore, no relationship was found between luteinized tissue area at the time of ET and pregnancy rate.


2008 ◽  
Vol 20 (1) ◽  
pp. 90 ◽  
Author(s):  
J. Small ◽  
F. Dias ◽  
L. Pfeifer ◽  
K. Lightfoot ◽  
M. Colazo ◽  
...  

In previous studies, giving eCG at CIDR removal significantly increased the pregnancy rate after timed-AI in beef cows. However, eCG is not universally available. Therefore, we tested the hypothesis that giving pFSH at CIDR removal might improve the pregnancy rate in a CIDR-based, Cosynch protocol in postpartum, suckled Bos taurus beef cows; a secondary objective was to compare pregnancy rates when GnRH v. pLH was used to synchronize wave emergence and ovulation. This work was conducted as two experiments (separate locations). All cows were given a CIDR (containing 1.9 g progesterone; Pfizer Animal Health, Montreal, QC, Canada) on Day 0 (without regard to stage of estrous cycle or cyclicity). On Day 7, CIDRs were removed, all cows were concurrently given 25 mg PGF (Lutalyse; Pfizer Animal Health, Groton, CT, USA), half were given 20 mg pFSH (Folltropin-V; Bioniche Animal Health, Belleville, ON, Canada), and all cows were timed-AI 54 h later (Day 9). In Experiment 1, 240 cows [94 � 10.8 days postpartum; body condition score (BCS: 1 = emaciated, 9 = obese; mean � SD): 5.8 � 0.4] were used; at CIDR insertion and AI, cows were allocated to receive either 100 µg GnRH (n = 160; Cystorelin, Merial Canada Inc., Victoriaville, QC, Canada) or 12.5 mg pLH (n = 80; Lutropin-V, Bioniche Animal Health). In Experiment 2, 109 cows (59.2 � 19.5 days postpartum; BCS: 5.6 � 1.1) were used; all received 100 µg GnRH (Cystorelin) at CIDR insertion and AI. In Experiment 1, three cows that lost their CIDR were excluded; pregnancy rates after timed-AI (logistic regression, backward selection: parity, pFSH, synchronizing treatment, and their interactions) were not different between cows given pFSH v. control cows (64.7 v. 65.2%; P > 0.80), nor between cows given GnRH v. pLH (62.7 v. 69.6%; P = 0.91). However, there was an interaction (P < 0.04) between parity and the synchronizing treatment; in primiparous cows, pregnancy rates were significantly lower in those given GnRH v. pLH (59.3 v. 83.3%). In Experiment 2, pregnancy rates after timed-AI (logistic regression, backward selection: parity, pFSH, and their interaction) were not different between cows given pFSH v. control cows (38.2 v. 42.6%; P > 0.6). In conclusion, our hypothesis was not supported; giving pFSH at CIDR removal did not significantly improve the pregnancy rate in a CIDR-based, Cosynch protocol in postpartum, suckled Bos taurus beef cows.


2009 ◽  
Vol 72 (7) ◽  
pp. 949-958 ◽  
Author(s):  
L.G.B. Siqueira ◽  
C.A.A. Torres ◽  
E.D. Souza ◽  
P.L.J. Monteiro ◽  
E.K.N. Arashiro ◽  
...  

Author(s):  
Michal Hulík ◽  
Ladislav Zeman

Effects of mycotoxin sequestering agents in feed on health, reproduction and milk yield of dairy cattle were studied in a 5-month long experiment on 300 dairy cows divided into two groups and six subgroups. The experiment was conducted in adding a mycotoxin sequestering agent based on 1,3 and 1,6 β-glucans to standard cattle nutrition (TMR), which was regularly tested for content of important mycotoxins, in order to gain knowledge about possible positive effect of this agent on the health of dairy cattle and about possible avoidance of negative effects of mycotoxins on dairy cattle due to their structural elimination caused by the agent. The experiment’s setting and conditions during it were in all aspects common and comparable within the European Union, the experiment’s results should be therefore seen as relevant. Health, pregnancy rate and milk yield were carefully monitored during the experiment. Indicators of state of health (occurrence of mastitis and somatic cell count in milk) did not show any significant differences between test and control groups of dairy cows. The average milk yield of dairy cows which were fed the agent enriched feed (30.2 kg a day) was slightly lower in comparison to control groups (31 kg a day, both results with P < 0.001), however, fat content of milk of test groups’ cows (4.02%) was considerably higher than that of control groups’ cows (3.79%). The average pregnancy rate of cows which were fed the agent enriched feed also manifested considerable increase in percentage and stability (from 42.95% of control groups’ cows to 62.25% of test groups’ cows, the standard deviation decreased from 21.1% to 14.4% which means smaller differences among pregnancy rate of test groups’ cows, hence higher stability), this increase manifested even long after the cows had been fed regular feed again.


2004 ◽  
Vol 16 (2) ◽  
pp. 212 ◽  
Author(s):  
T. Nishisouzu ◽  
M. Sugawara ◽  
S. Aoki ◽  
K. Kishida ◽  
M. Moriyoshi ◽  
...  

Treatments with GnRH and PGF2α for synchronization of ovulation has resulted in acceptable pregnancy rates after fixed-time artificial insemination in dairy cows without estrus detection. The objective of the present study was to evaluate the practicability of ovulation synchronization (Ovsynch, Pursley JR et al. 1995 Theriogenology 44, 915–923) in dairy cattle using GnRH and PGF2α for the embryo transfer recipients. Dairy cattle (cows; n=100, heifers; n=88) were randomly allocated to one of two groups. The control group (cows; n=45, heifers; n=37) was composed of cows in natural estrus. The ovulation synchronization group (cows; n=55, heifers; n=51) was treated with an intramuscular injection of 100μg of GnRH at a random stage of the estrous cycle. Seven days later, the cattle received PGF2α (Cows; 25–30mg) or PGF2α analog (Heifers; 0.5mg) in order to regress the corpora lutea (CL). Forty-eight hours later, cows and heifers received a second injection of 100μg GnRH. Embryo transfer was carried out 7 days after the second injection of GnRH in the ovsynch group and 7 days after estrus in the control group. The cattle judged to have CL 17mm were classified as acceptable recipients. The size of the follicles and the CL were determined to be of estrus stage and embryo transfer by means of ultrasonography. The mean numbers of follicles and CL were analyzed by ANOVA, while pregnancy rates were analyzed by chi-square test. The results are presented in the Table. The proportion of cows and heifers determined to be acceptable embryo transfers was not different between the control group and the ovsynch group. There were no differences in the proportion of acceptable embryo transfers between the control group and the ovsynch group. Follicle diameter at the time of estrus in the control group (cows; 20.7±0.7mm, heifers; 16.8±0.5mm) were significantly larger than that of the ovsynch group (cows; 18.0±1.0mm, heifers; 14.7±0.2mm) (P&lt;0.05). Although CL diameter at the time of embryo transfer in heifers showed no differences between the control group and the ovsynch group (25.0±1.0mm v. 22.8±1.5mm), The CL diameter of the control cow group was larger than that of the ovsynch group (29.8±0.7mm v. 26.1±1.0mm, P&lt;0.05). However, no differences in pregnancy rate were seen between the control group and the ovsynch group. These results suggest that ovsynch can be effectively applied in an embryo transfer program for cattle. Table 1 Proportion of acceptable embryo transfer recipients and pregnancy rate in dairy cattle in the control ovsynch groups


Sign in / Sign up

Export Citation Format

Share Document